OncoCyte News

OncoCyte | 424B3: Prospectus

Jun 5 05:08

OncoCyte | 8-K: Current report

Jun 1 04:10

OncoCyte | 8-K: Current report

May 24 04:12

OncoCyte | 424B3: Prospectus

May 23 23:30

OncoCyte | EFFECT: Others

May 23 18:05

OncoCyte | 4: Statement of changes in beneficial ownership of securities-Officer Liu James Yang

May 23 05:20

OncoCyte | 4: Statement of changes in beneficial ownership of securities-Director Arno Andrew

May 23 05:00

OncoCyte | 4: Statement of changes in beneficial ownership of securities-Officer Riggs Josh

May 23 05:00

OncoCyte | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)

May 18 05:14

OncoCyte | 8-K: ONCOCYTE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

May 16 10:26

OncoCyte | 10-Q: Quarterly report

May 16 04:18

OncoCyte | S-3: Registration statement for specified transactions by certain issuers

May 11 05:34

OncoCyte | DEF 14A: Definitive information statements

Apr 30 05:25

OncoCyte | D: Filing D

Apr 26 01:14

OncoCyte | SC 13G: Statement of acquisition of beneficial ownership by individuals-Bio-Rad Laboratories, Inc(8.99%)

Apr 23 01:31

OncoCyte | 10-K: Annual report

Apr 16 18:09

OncoCyte | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Broadwood Partners, L.P.(37.6%),Broadwood Capital, Inc.(37.6%), etc.

Apr 16 07:30

OncoCyte | 4: Statement of changes in beneficial ownership of securities-10% Owner BROADWOOD PARTNERS, L.P.

Apr 16 07:25

OncoCyte | 4: Statement of changes in beneficial ownership of securities-Director Arno Andrew

Apr 15 18:23

OncoCyte | 4: Statement of changes in beneficial ownership of securities-Officer Riggs Josh

Apr 15 18:19